Takeda Divests Assets to Hikma and Esteve
Deal News | Feb 06, 2025 | White & Case
Global law firm White & Case LLP has provided legal advisory services to Takeda Pharmaceutical Company Limited in two significant divestment transactions. The first transaction involves the sale of a portfolio of pharmaceutical products, currently licensed and marketed by Hikma Pharmaceuticals PLC, targeting select territories in the Middle East and North Africa (MENA). The second transaction concerns the divestment of the oncological product, MEPACT, to Esteve Pharmaceutical S.A. These divestments, contingent upon regulatory and antitrust approvals, are anticipated to be completed by 2025. Since 2019, White & Case has been a pivotal advisor to Takeda, assisting in various divestitures across several global regions. Takeda, headquartered in Japan, concentrates on multiple biopharmaceutical sectors, including oncology. Hikma and Esteve, the buyers in these transactions, are leading pharmaceutical companies in their respective regions.
Sectors
- Pharmaceuticals
- Legal Advisory
Geography
- Japan – Takeda Pharmaceutical Company Limited is headquartered in Japan.
- United Kingdom – Hikma Pharmaceuticals PLC, one of the acquiring companies, is based in the UK.
- Spain – Esteve Pharmaceutical S.A., the acquirer of MEPACT, is headquartered in Spain.
- Middle East and North Africa – One of the transactions involves the divestment of pharmaceutical products marketed in the MENA region.
Industry
- Pharmaceuticals – The article discusses divestment transactions involving pharmaceutical products and companies.
- Legal Advisory – White & Case LLP, a legal advisory firm, is providing legal counsel for the divestment transactions.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Takeda Pharmaceutical Company Limited | Seller | Company | A leading global biopharmaceutical company headquartered in Japan. |
| Hikma Pharmaceuticals PLC | Buyer | Company | A UK-listed global pharmaceutical company active in North America, MENA, and Europe. |
| Esteve Pharmaceutical S.A. | Buyer | Company | A Spain-headquartered global pharmaceutical company with a presence in Europe. |
| White & Case LLP | Legal Advisor | Company | An international law firm advising Takeda on the divestment transactions. |